MECP2 variants in this IDR are associated with several neurodevelopmental and psychiatric disorders [41,45], e.g., severe neonatal-onset encephalopathy with microcephaly, Rett syndrome, focal epilepsy, intellectual disability, and autism (S5 Table). Here, MECP2 is linked to focal epilepsy.